Menu Title

Scientific Research
FAQ
Blog
About
Formulators
Jemyll

Contact Us

Topic

Weight Loss

All Post
DC12
Energy
GLP-1
Insulin Resistance
Metabolism
Weight Loss

Topics

DC12
Energy
GLP-1
Insulin Resistance
Metabolism
Weight Loss

Popular Post

How an Innovation In Nutrition May Provide Unique Support for GLP-1 Therapy Users
Why Dietary Ketosis Fails. Three Tips.

Subscribe

Why Dietary Ketosis Fails. Three Tips.

DC12 Metabolism Weight Loss Insulin Resistance GLP-1 Energy

Why Dietary Ketosis Fails. Three Tips.

Dietary ketosis, or the ketogenic diet, has surged in popularity for its promise of weight loss,...

2 minute read

13 February 2025

Read More

How an Innovation In Nutrition May Provide Unique Support for GLP-1 Therapy Users

DC12 Metabolism Weight Loss Insulin Resistance GLP-1 Energy

How an Innovation In Nutrition May Provide Unique Support for GLP-1 Therapy Users

How Dodecanedioic Acid (DC12) Can Support Nutrition Needs for Semaglutide Users: A Look at...

2 minute read

30 January 2025

Read More

Subscribe to our newsletter "DC12 Advances"

Sign up for our latest scientific advances and applications of DC12 in functional foods and beyond.

Jemyll Limited is a pioneering biotech company, inventors of DiCarb^® Nutrition, and owners of the Metabolyte™ brand - a highly metabolically efficient ingredient set to revolutionize the global nutrition and health industries.

Engage

Blog
Press
About
Privacy Policy
Terms & Conditions

Get In Touch

Business and Scientific Inquiries: tim.avila@jemyll.com USA: Juan Capistrano, CA

UK Headquarters: 4.9 Hardwick House Waterfront Drive SW10 OJR London, United Kingdom

Copyright © 2025 Jemyll, LTD All Rights Reserved.

|